Substituted pyrrolo-pyrazole derivatives as kinase inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8481585
APP PUB NO 20130017170A1
SERIAL NO

13614499

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds represented by formula (Ia) or (Ib) and wherein R and R1 are as defined in the description, and pharmaceutically acceptable salts thereof, are disclosed; the said compounds are useful in the treatment of cell cycle proliferative disorders, e.g. cancer, associated with an altered cell cycle dependent kinase activity.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NERVIANO MEDICAL SCIENCES S R L20014 NERVIANO (MI)

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Amici, Raffaella Codogno, IT 19 336
Brasca, Maria Gabriella Cusago, IT 50 744
Fancelli, Daniele Milan, IT 43 288
Nesi, Marcella Saronno, IT 44 329
Orsini, Paolo Legnano, IT 47 763
Orzi, Fabrizio Milan, IT 12 69
Pevarello, Paolo Pavia, IT 65 1038
Roussel, Patrick Mulhouse, FR 43 237
Vulpetti, Anna Brugherio, IT 55 904

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 9, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00